H & H PHARMACEUTICALS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
H & H PHARMACEUTICALS
Largest movements
- Cash +€3.2m
up €3.2m (+158%), from €2.1m to €5.3m
mainly Net result for the year (+€8.4m) and Other debts (+€850,682)
- Financial fixed assets +€1.6m
up €1.6m (+4.8%), from €32.5m to €34.1m
- Receivables within one year +€931,038
up €931,038 (+19.6%), from €4.7m to €5.7m
of which Other amounts receivable: +€697,195
- Profit (loss) carried forward +€8.4m
up €8.4m (+46.1%), from €18.1m to €26.5m
- Debts after one year -€3.4m
down €3.4m (-18.4%), from €18.4m to €15.0m
- Other debts +€850,682
up €850,682 (+44,294%), from €1,921 to €852,603
- Financial income +€3.3m
up €3.3m (+66.9%), from €4.9m to €8.2m
- Financial charges -€1.8m
down €1.8m (-57.1%), from €3.2m to €1.4m
- Services and other goods +€101,101
up €101,101 (+245%), from €41,292 to €142,393
- Turnover -€63,632
down €63,632 (-3.7%), from €1.7m to €1.7m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €41,660,836 | €47,396,315 | +€5.7m | +13.8% |
| Fixed assets | 21/28 | €33,404,336 | €34,971,059 | +€1.6m | +4.7% |
| Intangible fixed assets | 21 | - | €16,696 | +€16,696 | |
| Tangible fixed assets | 22/27 | €896,644 | €896,644 | = | 0.0% |
| Land and buildings | 22 | €896,644 | €896,644 | = | 0.0% |
| Financial fixed assets | 28 | €32,507,691 | €34,057,718 | +€1.6m | +4.8% |
| Affiliated companies | 280/1 | €32,507,691 | €34,057,718 | +€1.6m | +4.8% |
| Participating interests | 280 | €32,507,691 | €34,057,718 | +€1.6m | +4.8% |
| Current assets | 29/58 | €8,256,501 | €12,425,257 | +€4.2m | +50.5% |
| Amounts receivable within one year | 40/41 | €4,746,806 | €5,677,844 | +€931,038 | +19.6% |
| Trade receivables | 40 | €333,911 | €567,753 | +€233,843 | +70.0% |
| Other amounts receivable | 41 | €4,412,896 | €5,110,091 | +€697,195 | +15.8% |
| Cash at bank and in hand | 54/58 | €2,052,164 | €5,294,689 | +€3.2m | +158% |
| Deferred charges and accrued income | 490/1 | €1,457,531 | €1,452,724 | -€4,807 | -0.3% |
| Total equity and liabilities | 10/49 | €41,660,836 | €47,396,315 | +€5.7m | +13.8% |
| Equity | 10/15 | €19,414,224 | €27,771,751 | +€8.4m | +43.0% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €1,275,000 | €1,275,000 | = | 0.0% |
| Distributable reserves | 133 | €1,275,000 | €1,275,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €18,129,224 | €26,486,751 | +€8.4m | +46.1% |
| Amounts payable | 17/49 | €22,246,613 | €19,624,564 | -€2.6m | -11.8% |
| Amounts payable after more than one year | 17 | €18,427,522 | €15,043,554 | -€3.4m | -18.4% |
| Financial debts | 170/4 | €18,427,522 | €15,043,554 | -€3.4m | -18.4% |
| Credit institutions | 173 | €18,427,522 | €15,043,554 | -€3.4m | -18.4% |
| Amounts payable within one year | 42/48 | €3,572,295 | €4,367,764 | +€795,470 | +22.3% |
| Current portion of amounts payable after more than one year | 42 | €3,441,991 | €3,497,877 | +€55,885 | +1.6% |
| Trade debts | 44 | €57 | €17,285 | +€17,228 | +30,225% |
| Suppliers | 440/4 | €57 | €17,285 | +€17,228 | +30,225% |
| Taxes, remuneration and social security | 45 | €128,326 | - | -€128,326 | |
| Taxes | 450/3 | €128,326 | - | -€128,326 | |
| Other amounts payable | 47/48 | €1,921 | €852,603 | +€850,682 | +44,294% |
| Accrued charges and deferred income | 492/3 | €246,796 | €213,246 | -€33,550 | -13.6% |
| Operating income | 70/76A | €1,735,507 | €1,671,876 | -€63,632 | -3.7% |
| Turnover | 70 | €1,735,507 | €1,671,876 | -€63,632 | -3.7% |
| Operating charges | 60/66A | €43,169 | €143,652 | +€100,483 | +233% |
| Services and other goods | 61 | €41,292 | €142,393 | +€101,101 | +245% |
| Other operating charges | 640/8 | €1,878 | €1,259 | -€618 | -32.9% |
| Operating profit (loss) | 9901 | €1,692,338 | €1,528,223 | -€164,115 | -9.7% |
| Financial income | 75/76B | €4,908,488 | €8,193,271 | +€3.3m | +66.9% |
| Recurring financial income | 75 | €4,908,488 | €8,193,271 | +€3.3m | +66.9% |
| Income from financial fixed assets | 750 | - | €8,193,271 | +€8.2m | |
| Other financial income | 752/9 | €4,908,488 | - | -€4.9m | |
| Financial charges | 65/66B | €3,177,651 | €1,363,660 | -€1.8m | -57.1% |
| Recurring financial charges | 65 | €3,177,651 | €1,363,660 | -€1.8m | -57.1% |
| Debt charges | 650 | - | €1,363,660 | +€1.4m | |
| Other financial charges | 652/9 | €3,177,651 | - | -€3.2m | |
| Profit (loss) for the period before taxes | 9903 | €3,423,174 | €8,357,834 | +€4.9m | +144% |
| Income taxes | 67/77 | - | €307 | +€307 | |
| Taxes | 670/3 | - | €307 | +€307 | |
| Profit (loss) for the period | 9904 | €3,423,174 | €8,357,527 | +€4.9m | +144% |
| Profit (loss) for the period to be appropriated | 9905 | €3,423,174 | €8,357,527 | +€4.9m | +144% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.